You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsDetails

華潤醫藥(03320.HK)旗下乳酸鈉林格注射液通過仿製藥質量和療效一致性評價

阿思達克 12-11 16:16
華潤醫藥(03320.HK)公布,集團旗下安徽雙鶴獲得國家藥監局頒發的乳酸鈉林格注射液《藥品補充申請批准通知書》,該藥品通過仿製藥質量和療效一致性評價。 乳酸鈉林格注射液為調節體液、電解質及酸鹼平衡藥,用於代謝性酸中毒或有代謝性酸中毒的脫水患者。
Relevant Stocks